iRhythm Confirms Material Patient Data Exfiltration via Third-Party Apps
Summary
iRhythm Holdings confirmed a material cybersecurity incident involving unauthorized activity on third-party business applications, resulting in the exfiltration of sensitive patient data through social engineering. This follows an 8-K filed today, June 15th, which also disclosed the material incident. While the company states no impact to its products, clinical systems, patient safety, or operations, the breach of patient data carries significant legal, regulatory, and reputational risks for the company.
At the time of this announcement, IRTC was trading at $113.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $101.75 to $212.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.